vandetanib (caprelsa) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$171.5973 - $342.5113

VA FSS

$236.4960 - $472.9920

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
vandetanib 100 mg (TABLET) $171.5973 VA Big4
  • CAPRELSA (30)
    		•  Genzyme Corporation dba Genzyme Therapeutics Division
    vandetanib 100 mg (TABLET) $236.4960 VA FSS
  • CAPRELSA (30)
    		•  Genzyme Corporation dba Genzyme Therapeutics Division
    vandetanib 300 mg (TABLET) $342.5113 VA Big4
  • CAPRELSA (30)
    		•  Genzyme Corporation dba Genzyme Therapeutics Division
    vandetanib 300 mg (TABLET) $472.9920 VA FSS
  • CAPRELSA (30)
    		•  Genzyme Corporation dba Genzyme Therapeutics Division

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue